Artificial intelligence is transforming modern medicine, opening up scenarios that were unimaginable just a few years ago. Today, thanks to Deep Learning, it is possible to analyze complex ultrasound images with greater accuracy and speed, supporting physicians in diagnosing diseases that are difficult to detect at an early stage.
Our whitepaper explores a concrete case: the application of deep neural networks to contrast-enhanced ultrasound (CEUS) for the detection of hepatocellular carcinoma (HCC) — the most common malignant liver tumor and one of the leading causes of cancer-related mortality worldwide.
The document illustrates how an AI system can:
- improve the reliability of CEUS by reducing dependence on the operator’s individual experience;
- guide the examination with real-time suggestions;
- automatically classify and track liver lesions;
- contribute to earlier diagnoses, reducing the need for more invasive and costly techniques.
An innovative approach that combines scientific rigor, clinical applicability, and patient-centered care.
Download the full whitepaper to discover how AI can revolutionize the diagnosis of hepatocellular carcinoma and pave the way for a more precise, equitable, and sustainable form of medicine.
Download
